• Data
  • Studio
  • Research
  • Resources
  • About
    • Blog
    • Members
    • Leadership
    • Governance
    • Events
    • Newsroom
    • Careers
Get started
Sign in
Real-world trends in APOE genetic testing associated with lecanemab

Real-world trends in APOE genetic testing associated with lecanemab

by Truveta Research | Nov 10, 2023 | Research, Research Insights

Lecanemab received accelerated FDA approval in January 2023 and full FDA approval in July 2023. A potential side effect of the drug is brain swelling and/or small hemorrhages and is most common for people with the APOE ε4 genetic variant, therefore rates of APOE e4...

Share this


Recent posts

  • First real-world comparative effectiveness study finds tirzepatide (Mounjaro) up to three times more effective than semaglutide (Ozempic) for weight loss
  • Beyond claims data: Truveta showcases potential of EHR data at ISPOR EU 2023
  • Reflections from the inaugural Truveta Symposium

Follow Truveta


Stay up-to-date

Ready to join us on our mission of Saving Lives with Data?

Get started
  • Follow
  • Follow

Truveta Data

Truveta Studio

Research

Resources

Blog

Leadership

Governance

Newsroom

Careers

Contact us

Privacy Notice

© Truveta 2023

Interested in learning more?

Reach out and we’ll schedule a demo.